Merck, Inc.
🇵🇭Philippines
A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)
Phase 4
Terminated
- Conditions
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 11
- Registration Number
- NCT00140920
Osteoporosis Disease Management Demonstration Project (0000-037)
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2016-04-22
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 10000
- Registration Number
- NCT00139425
Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2017-03-24
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 255
- Registration Number
- NCT00139932
Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038)
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2016-04-22
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 4266
- Registration Number
- NCT00139438
A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema
Phase 2
Withdrawn
- Conditions
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2013-05-21
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Registration Number
- NCT00135655
A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2015-07-30
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 106
- Registration Number
- NCT00132769
Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 1030
- Registration Number
- NCT00132912
An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2018-10-12
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 604
- Registration Number
- NCT00132730
A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)
- First Posted Date
- 2005-08-18
- Last Posted Date
- 2015-02-05
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 2400
- Registration Number
- NCT00131404
A Study of MK0364 in Obese Patients (0364-014)
Phase 3
Terminated
- Conditions
- First Posted Date
- 2005-08-18
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 2400
- Registration Number
- NCT00131391
© Copyright 2024. All Rights Reserved by MedPath